Dabigatran etexilate
Dabigatran Etexilate Mesylate is a generic prescription oral capsule medication, available in strengths of 75mg, 110mg, and 150mg (equivalent to base). Manufactured by Alembic Pharmaceuticals, it acts as a direct thrombin inhibitor to help prevent blood clots. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Dabigatran Etexilate Mesylate is a generic prescription oral capsule medication, available in strengths of 75mg, 110mg, and 150mg (equivalent to base). Manufactured by Alembic Pharmaceuticals, it acts as a direct thrombin inhibitor to help prevent blood clots. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Dabigatran etexilate",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Dabigatran etexilate — ANDA 214358 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214358"
}
]
|
| identifier | ANDA214358 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"drug-manufacturers",
"medications",
"pharmaceuticals",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Dabigatran etexilate |
